Recurrence of IgA Nephropathy in Renal Allografts

Overview

Journal Am J Kidney Dis

Specialty Nephrology

Date 1988 Nov 1

PMID 3055960

Citations 27

Authors

J Berger

Affiliations

Soon will be listed here.

Abstract

Mesangial IgA deposits recur in about half of the patients receiving a renal allograft for end-stage renal disease due to IgA nephropathy. However, the course of the recurrent disease is usually mild and rarely causes decreased function of the allograft.

Citing Articles

IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis.

Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D Pediatr Nephrol. 2024; 40(2):533-569.

PMID: 39331079 PMC: 11666671. DOI: 10.1007/s00467-024-06502-6.

O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.

Novak J, King R, Yother J, Renfrow M, Green T Glycobiology. 2024; 34(11).

PMID: 39095059 PMC: 11442006. DOI: 10.1093/glycob/cwae060.

Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.

Rajasekaran A, Green T, Renfrow M, Julian B, Novak J, Rizk D Drugs. 2023; 83(16):1475-1499.

PMID: 37747686 PMC: 10807511. DOI: 10.1007/s40265-023-01940-2.

Cytokines and Production of Aberrantly -Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy.

Person T, King R, Rizk D, Novak J, Green T, Reily C J Interferon Cytokine Res. 2022; 42(7):301-315.

PMID: 35793525 PMC: 9536348. DOI: 10.1089/jir.2022.0039.

Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study.

Jager C, Stampf S, Molyneux K, Barratt J, Golshayan D, Hadaya K BMC Nephrol. 2022; 23(1):178.

PMID: 35538438 PMC: 9088042. DOI: 10.1186/s12882-022-02802-x.